We are live on ! Find out more
RVNC

Revance Therapeutics, Inc.
RVNC

Delisted

RVNC was delisted on the 5th of February, 2025.

Back to rankings

70 hedge funds and large institutions have $426M invested in Revance Therapeutics, Inc. in 2015 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 31 increasing their positions, 15 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

107% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 15

28% more capital invested

Capital invested by funds: $334M → $426M (+$92.8M)

1% more funds holding

Funds holding: 69 → 70 (+1)

9% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 11

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

24% less call options, than puts

Call options by funds: $427K | Put options by funds: $560K

Holders
70
Holders Change
+1
Holders Change %
+1.45%
% of All Funds
1.86%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
12
Increased
31
Reduced
15
Closed
11
Calls
$427K
Puts
$560K
Net Calls
-$133K
Net Calls Change
-$87K

Top Buyers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
+$11.1M
2
JP Morgan Chase
JP Morgan Chase
New York
+$8.68M
3
GTC
Ghost Tree Capital
New York
+$3.46M
4
Bank of New York Mellon
Bank of New York Mellon
New York
+$2.43M
5
VAM
Visium Asset Management
New York
+$1.99M

Top Sellers

Rank Fund Capital Flow
1
AllianceBernstein
AllianceBernstein
Tennessee
-$9.83M
2
Ameriprise
Ameriprise
Minnesota
-$4.28M
3
JG
Jefferies Group
New York
-$1.69M
4
ZDA
Zweig-DiMenna Associates
New York
-$1.41M
5
Millennium Management
Millennium Management
New York
-$1.15M
Name Holding Trade Value Shares
Change 		Change in
Stake
Two Sigma Investments
26
Two Sigma Investments
New York
$1.07M +$893K +51,673 New
SI
27
Standard Investments
New York
$992K – – –
TI
28
Trexquant Investment
Connecticut
$897K +$441K +25,500 +143%
GOCM
29
Green Owl Capital Management
New York
$829K +$691K +40,000 New
Deutsche Bank
30
Deutsche Bank
Germany
$823K +$559K +32,354 +436%
B
31
Baird
Wisconsin
$713K +$26.8K +1,550 +5%
TCIM
32
TIAA CREF Investment Management
New York
$656K +$38.7K +2,240 +8%
BAMCO Inc
33
BAMCO Inc
New York
$622K -$225K -13,000 -30%
BIM
34
BlackRock Investment Management
Delaware
$558K +$7K +405 +2%
Charles Schwab
35
Charles Schwab
California
$553K +$26.1K +1,508 +6%
Two Sigma Advisers
36
Two Sigma Advisers
New York
$549K +$458K +26,500 New
State of New Jersey Common Pension Fund D
37
State of New Jersey Common Pension Fund D
New Jersey
$539K – – –
CS
38
Credit Suisse
Switzerland
$529K -$206K -11,914 -32%
SM
39
Sabby Management
Florida
$478K -$921K -53,335 -70%
ProShare Advisors
40
ProShare Advisors
Maryland
$431K +$55.8K +3,231 +18%
CCI
41
Columbus Circle Investors
$423K -$304K -17,594 -46%
Millennium Management
42
Millennium Management
New York
$412K -$1.15M -66,662 -77%
NA
43
Nottingham Advisors
New York
$389K -$73.5K -4,254 -18%
California State Teachers Retirement System (CalSTRS)
44
California State Teachers Retirement System (CalSTRS)
California
$330K – – –
NFA
45
Nationwide Fund Advisors
Ohio
$328K -$46.9K -2,714 -15%
QSS
46
Quantitative Systematic Strategies
Florida
$311K +$274K +15,850 New
Swiss National Bank
47
Swiss National Bank
Switzerland
$268K – – –
TA
48
Teachers Advisors
New York
$249K +$25.4K +1,471 +14%
AA
49
ALPS Advisors
Colorado
$244K +$204K +11,784 New
DekaBank Deutsche Girozentrale
50
DekaBank Deutsche Girozentrale
Germany
$230K +$192K +11,100 New
1
2
3 4

RVNC Hedge Fund Activity: Q1 2015 in Review

70 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Revance Therapeutics, Inc. (RVNC) for Q1 2015, worth a combined $426M — up 28% from $334M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new RVNC positions and 11 closed out — a net gain of 1 holder — while 31 added to existing stakes and 15 trimmed.

The largest buyer was Franklin Resources, adding an estimated $11.1M. The largest seller was AllianceBernstein, cutting an estimated $9.83M.

  • 70 institutional investors held Revance Therapeutics, Inc. (RVNC) as of Q1 2015, up from 69 in Q4 2014.
  • Funds reported $426M of Revance Therapeutics, Inc. stock for Q1 2015, up 28% quarter-over-quarter.
  • 12 funds opened new Revance Therapeutics, Inc. positions in Q1 2015 and 11 closed out, a net change of +1 holder.
  • The largest Revance Therapeutics, Inc. buyer in Q1 2015 was Franklin Resources, an estimated $11.1M added.
  • The largest Revance Therapeutics, Inc. seller in Q1 2015 was AllianceBernstein, an estimated $9.83M sold.

Based on aggregated 13F filings for Q1 2015.